Skip to main content
Premium Trial:

Request an Annual Quote

Zyomyx Receives Two US Patents for Biochips

NEW YORK, Sept. 12 (GenomeWeb News) - Zyomyx announced yesterday that the US Patent Office had recently issued the company two biochip patents.

 

The first, US Patent No. 6,582,969, was issued on June 24 of this year, and the second, US Patent No. 6,596,545 was issued on July 22. Both cover multiplexed, in vitro screening of biomolecular activity for drug development, clinical diagnostics, and proteomic and genomic research using miniaturized, micro-fabricated chips.

 

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.